orange ribbon

Editorial Vere Álvarez N

This neurodegenerative disease has become one of the leading causes of non-traumatic disability among young people. Currently, there is no direct cure, but recent research has determined that it is highly manageable thanks to medications, therapies, and healthy lifestyle habits.

 

The treatment of Multiple Sclerosis (MS) is moving in the right direction. According to the most comprehensive global study* To date, there are currently around 55.000 cases of multiple sclerosis detected In our country, which corresponds to 2% of the number of people who suffer from it Worldwide: 2,8 million. In other words, 1 of each 3.000 people live with the disease that has become the first cause of sudden neurological disability due to illness between the ages of 20 and 40, being more frequent in women than in men; and the second cause of disability in young people after traffic accidents.

Multiple Sclerosis (MS) is a neurodegenerative, autoimmune, and chronic disease that affects the Central Nervous System, which occurs with outbreaks or specific alterations in specific areas of the brain, producing diverse symptoms in any part of the body: loss of vision, sensory disturbances, weakness in some of the limbs causing mobility problems, fatigue, bladder problems, people more prone to problems with drowsiness or depression...

The thousand faces of MS

This great variety of Symptoms do not appear in all people, nor do they do it with the same intensity, hence this heterogeneous character makes it called the 'disease of a thousand faces' because the way it presents itself in each patient is different. Due to this peculiarity, it is done more complicated to achieve a cure, which does not exist today, and its study is more tedious, but there are increasingly effective treatments and research continues to better understand and treat the disease.

The data Spanish Society of Neurology (SEN) reflect that 1.800 new cases are diagnosed in Spain each year. With no cure and no known cause, the genetic component seems to be related. neurologist Dr. Jesús Romero Imbroda explains that the last 25 years have developed new drugs and treatments that can help manage the evolution and its outbreaks. Thanks to this, MS is very controllable, especially during the early stages of the disease.

Based on a treatment with drugs, Of nails rehabilitation therapies and maintaining Healthy Habits, people with Multiple Sclerosis can expect a good quality of life. “This disease, incurable throughout the 20th century, now has, thanks to recent studies and research, great expectations and life expectancy that are almost close to normal", says Dr. Romero Imbroda.

Tireless research

May 30th is World Awareness Day with the aim of support and raise awareness about how it affects the lives of those who suffer from it. In this way, forces are joined in the face of research and studies. As the Multiple Sclerosis Foundation (FEM), MS research continues"The main lines of research focus on myelin deficiency, immune system dysfunction, and neurodegeneration. The development of new drugs represents a direct improvement in quality of life and a shot in the arm for the future of many people."

In addition, recently, a group of scientists from the Trinity College from Dublin have made a important discovery that could lead to more effective treatments for people with multiple sclerosis (MS). Their work highlights the significant potential of drugs targeting a specific immune molecule (IL-17).

If you need more information about Multiple Sclerosis and its treatment, please do not hesitate to contact Clínica Dr. Mosqueira at 951006638. Our colleague Dr. Jesús Romero Imbroda will provide you with the information and assistance you need.

*The Multiple Sclerosis (MS) Atlas of the Multiple Sclerosis International Federation (MSIF) is the most comprehensive study of the epidemiology of MS and the availability and accessibility of resources for people with this neurodegenerative disease worldwide.

© 2026 Clínica Dr. Mosqueira - By Dani Barrios & Javi Arán